Kingsview Wealth Management LLC Has $5.03 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Kingsview Wealth Management LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,940 shares of the healthcare conglomerate’s stock after selling 521 shares during the quarter. Kingsview Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,028,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the 3rd quarter worth $27,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth $37,000. Friedenthal Financial purchased a new position in UnitedHealth Group during the 3rd quarter worth $51,000. Finally, Highline Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $55,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.6 %

Shares of UNH opened at $526.68 on Friday. The company has a market capitalization of $484.69 billion, a PE ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The business’s 50 day moving average is $529.18 and its 200 day moving average is $564.30. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $5.83 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on UNH shares. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Finally, Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.